The Zacks Analyst Blog Highlights Amgen, Crinetics, FBT, BBH and BBP
Biotech ETFs are riding innovation, obesity drug growth and M&A, offering diversified exposure to the sector???s powerful rally.
Zacks
More News
Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth
Biotech ETFs are riding a powerful rally fueled by innovation, obesity drugs and M&A, with three funds offering diversified exposure to growth.
Zacks
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Smart Beta ETF report for FBT
Zacks
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Sector ETF report for FBT
Zacks
ONC Stock Gains As BeOne Medicines Wins US Nod For BEQALZI In Rare Lymphoma
The FDA approved BEQALZI in the treatment of certain mantle cell lymphoma patients on Wednesday.
Stocktwits
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Smart Beta ETF report for FBT
Zacks
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Sector ETF report for FBT
Zacks
SRPT Stock Clocks Highest Daily Gain In Nearly 8 Years After Rare Muscle Disorders Study Data But Wall Street's Not Wholly Convinced
Leerink analyst Joseph Schwartz said the initial data released by the company in genetic diseases DM1 and FSHD1 are "a bit of a mixed bag."
Stocktwits
Sarepta Shares Rise As Company Begins Enrollment In Gene Therapy Safety Enhancement Study
Data from the study cohort is aimed at determining whether administering sirolimus prior to and after Elevidys infusion can help reduce risks associated with the gene therapy.
Stocktwits
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?